Adverse Event Reporting
| VAERS ID | 1866416 |
|---|---|
| Gender | Female |
| Age | 84 |
| StateCode | FR |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | |
| Number of vaccinations | 3 |
| Vaccinated | 2021-10-06 |
| Onset | 2021-10-06 |
| Condition | Hospitalized Died |
Symptoms
- SARS-CoV-2 test
- Immunisation
- Lower respiratory tract infection
- Off label use
- Cerebral haemorrhage
Current Illness
Preexisting Conditions
Medical History/Concurrent Conditions: Fracture femur; Fracture treatment
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
Write-up
bleed on the brain; Chest infection; Off-label use; Booster; This is a spontaneous report from a contactable consumer.
This is a report received from the Regulatory Authority.
Regulatory authority report number GB-MHRA-WEBCOVID-202110292048209670-YRAOG, Safety Report Unique Identifier GB-MHRA-ADR 26140836.
An 84-year-old female patient received bnt162b2 (COMIRNATY, lot number unknown), via an unspecified route of administration on 06Oct2021 (at the age of 84 years old) as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunisation.
Medical history included broken femur and major surgery to repair a broken femur 18 months prior.
Patient has not had symptoms associated with COVID-19.
Concomitant medication included influenza vaccine (INFLUENZA VIRUS) on 06Oct2021.
The patient previously took the dose 1 and dose 2 of COVID-19 vaccine for COVID-19 immunisation.
Primary Immunization series complete but unknown manufacturer.
The patient was immobalised on 08Oct2021 and ambulanced to hospital and was reported as having had a bleed on the brain and having a chest infection on 07Oct2021.
Treatment given was antibiotics and oxygen over a period of 2 weeks.
The patient underwent lab tests and procedures which included COVID-19 virus test was no - negative COVID-19 test.
Patient has not tested positive for COVID-19 since having the vaccine.
Patient is not enrolled in clinical trial.
The patient died on 22Oct2021.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.
; Reported Cause(s) of Death: off-label use; interchange of vaccine products; booster; Chest infection; Cerebral bleeding